In BRCA patients, DNMT1, NOP2, DNMT3A, FMR1, RBM15 and YTHDF2 were highly elevated, while WTAP, TET2, ALKBH3 and TRDMT1 were dramatically downregulated (Fig. 9B). Here, YTHDF2 is linked to invasive breast carcinoma.